Breast and Gynecologic Cancer Research Group

Programs and Projects

Ongoing Phase I/II Prevention Trials Funded and Monitored by the Breast and Gynecologic Cancer Research Group (BGCRG)

Principal Investigator	Funding Mechanism	Title of Award	Chemopreventive Agent
Robert Park, MD Gynecologic Oncology Group	Master Agreement	Fenretinide as Chemoprevention in Ovarian Carcinoma	4-HPR
Molly Brewer, MD University of Arizona	Master Agreement	A Multicenter Randomized Double-Blinded Trial for Chemoprevention of Ovarian Cancer: Modulation of Biomarkers and Spectral Properties using Contrast Enhanced Ultrasound In High-risk Women using Fenretinide (4-HPR) NCT00098800	4-HPR Placebo

** indicates studies that are open to accrual